Keyword: therapeutics

News

Allergan and Novartis Link on NASH

08.05.2017 - Major drug makers Allergan and Novartis are collaborating to test a new combination therapy for non-alcoholic steatohepatitis (NASH), a progressive form of fatty liver disease said...

News

Marathon Sells Emflaza to PTC Therapeutics

20.03.2017 - US drugmaker Marathon Pharmaceuticals has sold all rights to its Duchenne muscular dystrophy (DMD) drug Emflaza (deflazacort) to PTC Therapeutics in a deal that could be...

News

Pfizer Said Looking for Gene Therapy Site

13.03.2017 - After acquiring the remaining stake in Bamboo Therapeutics, a privately held gene therapy group based in Chapel Hill, North Carolina, USA, last year in a drive to be a major player...

News

Silence Buys Into Arrowhead Pharmaceuticals

16.01.2017 - UK-based Silence Therapeutics has acquired an 8.4% equity stake in US biotech group Arrowhead Pharmaceuticals to potentially advance progress in novel RNA therapeutics. Silence...

News

Allergan Buys US Chase Pharmaceuticals

24.11.2016 - Irish drugmaker Allergan has beefed up its pipeline for neurodegenerative disorders with the acquisition of US-based Chase Pharmaceuticals. Under the terms of the deal, Allergan...

News

Allergan Acquires Akarna Therapeutics

04.10.2016 - Continuing its recent spending spree, Allergan has bought Akarna Therapeutics for $50 million in cash. The privately held biopharmaceutical company, which has dual headquarters in...

News

Drug Approvals Said Driving US Pharma Deals

31.05.2016 - Large innovative US pharmaceutical companies will continue seeking bolt-on acquisitions as the need for larger transactions has declined, says the ratings agency Fitch, adding that...

Strategy & Management

Significant Value Creation

03.09.2015 - In September 2014, Merck announced the €13.1 billion acquisition of Sigma-Aldrich, which by mid-August has received antitrust clearance from all relevant jurisdictions including...